BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hromic-Jahjefendic A, Lundstrom K. Viral Vector-Based Melanoma Gene Therapy. Biomedicines 2020;8:E60. [PMID: 32187995 DOI: 10.3390/biomedicines8030060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Dymova MA, Kichkailo AS, Kuligina EV, Richter VA. Aptamers Enhance Oncolytic Viruses' Antitumor Efficacy. Pharmaceutics 2022;15. [PMID: 36678780 DOI: 10.3390/pharmaceutics15010151] [Reference Citation Analysis]
2 Viegas JSR, Bentley MVLB, Vicentini FTMDC. Challenges to perform an efficiently gene therapy adopting non-viral vectors: Melanoma landscape. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103964] [Reference Citation Analysis]
3 Freitas MV, Frâncio L, Haleva L, Matte UDS. Protection is not always a good thing: The immune system's impact on gene therapy. Genet Mol Biol 2022;45:e20220046. [PMID: 35852088 DOI: 10.1590/1678-4685-GMB-2022-0046] [Reference Citation Analysis]
4 Cheng TM, Chu HY, Huang HM, Li ZL, Chen CY, Shih YJ, Whang-Peng J, Cheng RH, Mo JK, Lin HY, Wang K. Toxicologic Concerns with Current Medical Nanoparticles. Int J Mol Sci 2022;23:7597. [PMID: 35886945 DOI: 10.3390/ijms23147597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jung B, Kim YJ, Hong J, Chang H, Yoon A, Yun C. ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells. IJMS 2022;23:7127. [DOI: 10.3390/ijms23137127] [Reference Citation Analysis]
6 bin Umair M, Akusa FN, Kashif H, Seerat-e-fatima, Butt F, Azhar M, Munir I, Ahmed M, Khalil W, Sharyar H, Rafique S, Shahid M, Afzal S. Viruses as tools in gene therapy, vaccine development, and cancer treatment. Arch Virol. [DOI: 10.1007/s00705-022-05432-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Sayed N, Allawadhi P, Khurana A, Singh V, Navik U, Pasumarthi SK, Khurana I, Banothu AK, Weiskirchen R, Bharani KK. Gene therapy: Comprehensive overview and therapeutic applications. Life Sci 2022;294:120375. [PMID: 35123997 DOI: 10.1016/j.lfs.2022.120375] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
8 Lundstrom K. Self-Replicating RNA Viruses for Vaccine Development against Infectious Diseases and Cancer. Vaccines (Basel) 2021;9:1187. [PMID: 34696295 DOI: 10.3390/vaccines9101187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Chis AA, Dobrea CM, Rus LL, Frum A, Morgovan C, Butuca A, Totan M, Juncan AM, Gligor FG, Arseniu AM. Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy. Molecules 2021;26:5976. [PMID: 34641519 DOI: 10.3390/molecules26195976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Lundstrom K. Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19. Viruses 2020;12:E1324. [PMID: 33218001 DOI: 10.3390/v12111324] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
11 Kuryk L, Bertinato L, Staniszewska M, Pancer K, Wieczorek M, Salmaso S, Caliceti P, Garofalo M. From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review. Cancers (Basel) 2020;12:E3057. [PMID: 33092131 DOI: 10.3390/cancers12103057] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
12 Ebrahimi Z, Talaei S, Aghamiri S, Goradel NH, Jafarpour A, Negahdari B. Overcoming the blood–brain barrier in neurodegenerative disorders and brain tumours. IET nanobiotechnol 2020;14:441-8. [DOI: 10.1049/iet-nbt.2019.0351] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]